Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ag, Beniashvili"'
Autor:
Margarita Morozova, Ge, Rupchev, Ig, Kozhekin, Tb, Arsenieva, Ra, Cheremin, Vn, Yachmenev, Ey, Onegina, Ak, Shvedova, Ag, Beniashvili, Ds, Burminsky, Ta, Lepilkina, Ss, Potanin
Publikováno v:
Europe PubMed Central
Our study was based on the hypothesis that a non competitive antagonist of NMDA receptors can improve clinical effects of antipsychotic therapy in a subgroup of patients with schizophrenia with clinical signs of glutamatergic hyperfunction such as ca
Publikováno v:
Europe PubMed Central
A comparative study of the platelet resistance to different effects was conducted in patients with chronic schizophrenia and healthy controls using column chromatography on sepharose CL-2B with the incubation at 5 degrees C during 18 h. This method a
Publikováno v:
Europe PubMed Central
An objective of the study was to investigate the effectiveness of neuromidin in stable schizophrenic patients with predominance of symptoms of pseudoorganic deficits. Fifty-five patients stable after a transition from routine medication to monotherap
Autor:
Os, Brusov, Mi, Faktor, Gp, Zlobina, Am, Dupin, Ab, Katasonov, Ad, Dmitriev, Ev, Pavlova, Ag, Beniashvili, Margarita Morozova
Publikováno v:
Europe PubMed Central
A sample included 59 patients, 38 males and 21 females, mean age (M+/-SD) 33,4+/-10,2 years, age-at-onset 26+/-9,5 years, illness duration 7,8+/-6,1 years, with episodic progressive schizophrenia (ICD-10: schizophrenia, paranoid type, F20.0) with con
Publikováno v:
Europe PubMed Central
Thirty adult patients with acute schizophrenia were included into six-week open-labelled, non-comparative trial of olanzapine with free dosing from 5 to 20 mg per day. For assessment of efficacy and safety of the treatment PANSS, BPRS, CGL and ESRS s
Autor:
Ar, Belous, Rammamoorthy S, Rd, Blakely, Mi, Factor, Am, Dupin, Ab, Katasonov, Lozier RKh, Ag, Beniashvili, Margarita Morozova, Os, Brusov
Publikováno v:
Europe PubMed Central
The role of serotonin transporter (SERT) protein in the development of somatoform disorders (SD) was investigated. An association study was performed in terms of the evaluation of the level of SERT immunoreactive (IR-SERT) protein using site-specific
Autor:
Os, Brusov, Mi, Faktor, Gp, Zlobina, Am, Dupin, Ab, Katasonov, Nk, Kartseva, Ag, Beniashvili, Nb, Zharkova, Vv, Rubashkina, Margarita Morozova
Publikováno v:
Europe PubMed Central
Fifty-nine patients, 21 women and 38 men, with ICD-10 diagnosis of schizophrenia (F20.0), attack-like type, were treated with olanzapine during 28 weeks (8-weeks of acute and 20-weeks of maintenance therapy). Evaluation of clinical symptoms measured
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::b1bfe06ee281cb884901719fcecb8d74
http://europepmc.org/abstract/med/15825226
http://europepmc.org/abstract/med/15825226
Autor:
Os, Brusov, Mi, Faktor, Gp, Zlobina, Pv, Bologov, Vg, Kaleda, Iv, Oleĭchik, An, Korenev, An, Piatnitskiĭ, Am, Dupin, Ab, Katasonov, Margarita Morozova, Ag, Beniashvili, Lozier RKh, Ev, Pavlova, Ol, Segal, Massino IuS, Ad, Dmitriev
Publikováno v:
Europe PubMed Central
Polyclonal (PAb) and monoclonal (MAb) antibodies to CT2-epitope of the C-terminal fragment of serotonin transporter (SERT) protein were used to study the levels and molecular heterogeneity of platelet SERT in healthy donors and patients with affectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::06c9714c4433ff727f6c5505f913f4f8
http://europepmc.org/abstract/med/11523428
http://europepmc.org/abstract/med/11523428